Perfusion solutions | Tenderlake

Perfusion solutions

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
24 May 2023
Closing Date:
26 June 2023
Location(s):
BE1 RÉGION DE BRUXELLES-CAPITALE/BRUSSELS HOOFDSTEDELIJK GEWEST (BE Belgium/BELGIQUE-BELGIË)
BE3 RÉGION WALLONNE (BE Belgium/BELGIQUE-BELGIË)
Description:
Doxorubicin in pegylated liposomes IV

Market for the supply of doxorubicin in pegylated liposomes intravenously dosage 10 ML and 25 ML.

Supply of doxorubicin in pegylated liposomes intravenously dosage 10 ML and 25 ML.

Download full details as .pdf
The Buyer:
MercurHosp ASBL
CPV Code(s):
33692400 - Perfusion solutions